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Abstract 
Objectives: The aim of these analyses was to examine the association between cortisol, 
dehydroepiandrosterone sulphate (DHEAS), and the cortisol:DHEAS ratio and mortality. 
Design: This was a prospective cohort analysis. Methods: Participants were 4255 Vietnam era US 
army veterans. From military service files, telephone interviews, and a medical examination, 
occupational, socio-demographic, and health data were collected.  Contemporary morning fasted 
cortisol and DHEAS concentrations were determined.  Mortality was tracked over the subsequent 
15 years. The outcomes were all-cause, cardiovascular disease, cancer, other medical mortality and 
external causes of death. Cox proportional hazard models were tested, first with adjustment for age 
and then additionally adjusting for a range of candidate confounders. Results: In general, cortisol 
concentrations did not show an association with all-cause or cause-specific mortality.  However, in 
age- and fully-adjusted analyses, DHEAS was negatively related to all-cause, all cancers, and other 
medical mortality; high DHEAS concentrations were protective.  The cortisol:DHEAS ratio was 
also associated with these outcomes in both age- and fully-adjusted models; the higher the ratio the 
greater the risk of death.  Conclusions: DHEAS was negatively, and the ratio of cortisol to DHEAS 
was positively associated with all-cause, cancer, and other medical cause mortality.  Further 
experimental study is needed to elucidate the mechanisms involved in these relationships.  
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The corticosteroid hormone cortisol, a component of the hypothalamic-pituitary-adrenal (HPA) 
axis, has a key role in the stress response 1, and has some immunosuppressive effects 2.  Higher 
circulating cortisol levels have been observed in critically ill intensive care patients 3, such as those 
experiencing septic shock and trauma 4.  Another adrenal cortex hormone, dehydroepiandrosterone 
(DHEA), is a precursor to sex hormones and is present in the circulation, predominantly as its 
sulphated form dehydroepiandrosterone sulphate (DHEAS).  DHEA/DHEAS appears to 
counterbalance many of the negative effects of cortisol on immunity 5, 6.  For example, it has been 
shown in vitro that higher cortisol suppresses neutrophil function and this effect can be overcome 
by co-incubation with DHEAS 7, 8.  Higher levels of DHEAS are also associated with less serious 
illness among intensive care patients 3, 4, 9.  Moreover, it appears that the activity of the HPA axis as 
reflected in the ratio of cortisol to DHEA is particularly important with regard to health.  The 
production of DHEAS declines in older age, a phenomenon termed adrenopause, while the 
production of cortisol remains stable, resulting in higher cortisol:DHEA ratios. This altered ratio 
has been associated with the age-related loss of immunity (immunesenescence), 2, 7, 10 as well as 
with non-immunity related psychological outcomes such as higher anxiety, mood disturbance, 
confusion, and poorer cognitive performance 11. 
 
In cohort studies, cortisol and DHEA levels have also been linked to mortality.  For 
example, higher cortisol was associated with increased mortality in patients with heart failure12, 
sepsis 13, and stroke 14, although this is not a universal finding  15.   DHEAS has been shown to be 
negatively associated with total and cardiovascular disease mortality in selected studies. in women 
with ischaemic heart disease 16, all-cause mortality in men only17, 18, both sexes 19 and both all-cause 
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and cardiovascular disease mortality in older people 20.  Others have found no association with 
either disease or all-cause mortality 21.  Surprisingly, few studies have examined the 
cortisol:DHEA/S ratio in association with mortality.  However, one study of septic shock and 
trauma patients revealed higher cortisol, lower DHEAS, and a higher cortisol:DHEA ratio among 
those who were more seriously ill and non-survivors 4.   The ratio also predicted all-cause but not 
disease mortality in US men who had fought in Vietnam in the present sample 22.  What is not 
known is whether serum cortisol and DHEAS alone predict all-cause mortality in this sample, and 
whether cortisol, DHEAS, and their ratio are associated with mortality from other causes such as 
cancer and non-medical causes.  As cortisol, DHEAS, and their ratio are associated with a variety of 
health outcomes, particularly immune-related measures 7, 10, 23, 24), it might be expected that they 
relate to death from particular causes.  Consequently, the present analyses examined the association 
between cortisol, DHEAS, their ratio and all-cause, cardiovascular disease, cancer mortality, other 
medical causes, and external causes of death in a substantial cohort of male military veterans. 
 
Materials and Methods 
 
Sample 
Participants (N = 4255) were identified retrospectively from data gathered as part of the Vietnam 
Experience Study; an epidemiological study commissioned by the US congress to investigate the 
health consequences of the military experiences of Vietnam veterans.  Participants were male 
military personnel drawn from approximately five million US Vietnam-era Army veterans whose 
service files were stored at the National Personnel Records Center 25.  The Centers for Disease 
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Control, Atlanta, had access to U.S. Veteran Administration records and provided the authors with a 
fully anonymised dataset.  Ethical approval for the study was given by the various relevant bodies, 
including the US Centers for Disease Control.  Eligibility criteria are published elsewhere, and the 
final cohort with complete data included 18,313 former military personnel 25-27.   
 
Data collection 
Information pertaining to place of service and ethnicity was extracted from the military 
archives.  Participants were designated as being Vietnam veterans if they had served at least one 
tour of duty in Vietnam, and as non-Vietnam veterans if they did not (this group included men who 
served one or more tours of duty in Korea, Germany or the US). The ethnic origin of the study 
members were classified as ‘white’, ‘black’,  or ‘other’; the latter group comprising Hispanics, 
Asians, Pacific Islanders, American Indians, and Alaskan Natives.  Of those included in the original 
cohort, 17,867 were considered to be alive on December 31, 1983 and therefore eligible for active 
follow-up.  In 1985, participants were invited to participate in a telephone interview.  Of those 
traced (N = 16,349), 15,288 men were able to participate in the 1985 telephone survey (85.6% of 
those alive on December 31st 1983) 27.  From the telephone survey, educational grade achieved at 
school (<11th grade, 12th grade, >12th grade) and household income in midlife (≤ $20k; -$40k, > 
$40k per year) were determined as measures of socio-economic status.  Frequency of alcohol 
consumption (units per week), cigarette smoking habits and marital status were ascertained using 
standard questions.  Participants were also asked whether or not they had a range of somatic 
physician-diagnosed health problems which included hypertension, cancer, diabetes and coronary 
heart disease 28, 29.  
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In 1986, a random sample of telephone interview respondents (N=6,443) were invited to 
attend a three day medical examination with orientation at a single facility in Albuquerque, New 
Mexico, for which travel expenses and a nominal stipend were paid; 4,462 men representative of the 
original cohort attended (69.3% of those invited).  The mean age at medical examination was 38.3 
years (range: 31.1 to 49.0).  The final number of participants with complete data after the medical 
examination was 4,256.  This group represents 23.3% of persons originally enrolled in the study.  
Serum cortisol and DHEAS were assayed in serum from a fasted blood sample using a double 
antibody radioimmunoassay system (Leeco Diagnostics, Inc., Southfield, MI).  All laboratory 
assays were assured by using bench and blind repeat controls. The blind repeat tests were run for 
one in 20 randomly chosen samples; the correlations between first and repeat samples exceeded 0.98.    
Bench controls yielded intra and inter-assay coefficients of variation that were all < 10%.  With the 
participant in a sitting position, a registered nurse, using a standard mercury sphygmomanometer 
measured blood pressure twice consecutively, from both arms.  For analysis, an average of the two 
right arm systolic and diastolic blood pressure values was computed.  Measurements from the left 
arm were used to verify individual results.   
 
The vital status of men between army discharge and December 31st 1983 (the date the cohort was 
established) was ascertained by cross-checking against a variety of mortality databases supplied by 
the US army, the Veterans Administration (Beneficiary Identification and Records Locator 
Subsystem), the Social Security Administration, the Internal Revenue Service, and the National 
Center for Health Statistics (National Death Index).   Vital status post-medical exam continued to be 
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ascertained until 31st December 2000 using the mortality databases described above.  Mortality due 
to major CVD was classified using the International Classification of Diseases (ICD) 30 codes: ICD-
9: 390–434,436–448, and ICD-10: I00–I78 which comprised: acute rheumatic fever; chronic 
rheumatic heart diseases; hypertensive diseases; ischaemic heart diseases; pulmonary heart disease 
and diseases of pulmonary circulation; other forms of heart disease; cerebrovascular diseases; 
diseases of arteries, arterioles and capillaries.  The CVD mortality variable thus encompasses death 
from a variety of disorders; the bulk of the deaths were from ischaemic heart diseases.  Mortality 
from cancer was classified using the International Classification of Diseases (ICD) codes: ICD-9: 
140–239, ICD-10: C00–D48 which include malignant neoplasms of all specified areas, Hodgkins 
disease, non-Hodgkins lymphoma, leukaemia, multiple myeloma, immunoproliferative neoplasms, 
and other malignant neoplasms of unspecified areas.  Of the cancers, the most frequent cause of 
death (N = 19) was from malignant neoplasms of the trachea, bronchus and lung.  External causes of 
death included those coded as ICD-9: E800–E999, ICD-10: V01–Y8, including accidents, suicide, 
and homicide.  Half of the deaths in this category were from suicide or homicide.  Finally, ‘other’ 
causes of death were calculated as all-cause mortality minus the other classifications, and consisted 
of infectious diseases, liver diseases/failure, kidney diseases/failure, and respiratory diseases.  The 
most frequent causes of death in this category were from infection, including infection with Human 
Immunodeficiency Virus (HIV), and from liver disease.  4255 men were included in the analyses 
reported below. 
 
Statistical analysis 
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Due to their skewed distribution, cortisol and DHEAS values were log–transformed, as was the 
cortisol:DHEAS ratio.  All covariates analysed in the study conformed to the assumption of 
proportional hazards over time; partial residuals were all randomly distributed.  Having confirmed 
that the proportional hazards assumption had not been violated, Cox’ proportional hazard regression 
was used to examine the relationships between cortisol, DHEAS, their ratio and mortality, in age-
adjusted analyses.  Demographic, military service, health behaviour and metabolic variables were 
compared between those who had and had not died using univariate Cox’ proportional hazard 
regression.   Further multivariate analyses of the relationships between cortisol, DHEAS, their ratio 
and mortality were then run, additionally adjusting for significant covariates, including some or all 
of place of service, ethnicity, marital status, alcohol consumption, smoking, household income, and 
physical illness diagnosis.  Only those covariates significant in the univariate prediction of mortality 
were included as covariates in the fully-adjusted models.   
 
Results 
All-cause mortality 
The arithmetic mean (SD) serum cortisol and DHEAS values for the whole sample were 18.2 (5.52) 
and 239.8 (99.86) µg/dl, respectively.  This equates to 502.1 (152.30) and 832.1 (346.51) nmol/L, 
respectively.  The mean (SD) cortisol to DHEAS ratio was 0.09 (0.06).  During the 15 years of 
follow-up there were 236 deaths.  Table 1 shows the univariate predictions of all-cause mortality.  
Higher mortality was associated with service in Vietnam rather than another overseas location, not 
being married, being non-white, smoking, having a physical illness, lower household income in 
midlife, higher systolic blood pressure (SBP), and higher alcohol consumption.  Table 1 also shows 
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the univariate hazard ratios for cortisol, DHEAS, and cortisol:DHEAS ratio predicting all-cause 
mortality.  Age-adjusted analyses revealed that higher cortisol concentrations were associated with a 
higher all-cause mortality risk, hazard ratio (HR) = 1.71, 95% confidence interval (CI) = 1.12 – 
2.62, p = .013.  Conversely, those with higher DHEAS levels were at a decreased risk of death, HR 
= 0.51, 95%CI = 0.38 – 0.66, p < .001.  The cortisol:DHEAS ratio was significantly related to 
mortality risk, HR = 2.05, 95%CI = 1.61 – 2.61, p < .001, such that individuals with a higher ratio 
were at greater risk of death.  Following adjustment for age and the other covariates collectively, the 
association between cortisol and mortality was no longer statistically significant at conventional 
levels (HR = 1.32, 95%CI = 0.86 – 2.03, p = .20).  However, higher DHEAS levels were still 
related to lower mortality risk, HR = 0.55, 95%CI = 0.43 – 0.71, p < .001, and the cortisol:DHEAS 
ratio remained significantly and positively associated with mortality, HR = 1.76, 95% CI = 1.40 – 
2.23, p < .001. 
 
[Insert Table 1 about here] 
 
Cardiovascular disease and cancer mortality 
Sixty-three participants died of CVD; Table 2 shows the hazard ratios for the univariate predictors 
of CVD mortality.  Participants who had died of CVD were slightly older, were more likely to have 
served in Vietnam than another overseas location, were more likely to be 
divorced/widowed/separated, Black, smokers, in the lowest household income in midlife tertile, and 
have a physical illness, higher systolic blood pressure (SBP), but not have higher alcohol 
consumption.  Table 2 also presents the univariate hazard ratios for cortisol, DHEAS, and their ratio 
Post-print, not final published version. Cite this article as: Phillips, A.C., Carroll, D., Gale, C.R., 
Lord, J.M., Arlt, W., & Batty, G.D. (2010). Cortisol, dehydroepiandrosterone sulphate, their ratio 
and all-cause and cause-specific mortality in the Vietnam Experience Study. European Journal 
of Endocrinology, 162, 919-923. http://dx.doi.org/10.1530/EJE-09-1078 
 
 
predicting CVD mortality status.  Age adjusted analyses indicated that cortisol, DHEAS, and the 
cortisol:DHEAS ratio were not associated with CVD mortality.  The hazard ratios for the univariate 
predictors of mortality from cancer are also presented in Table 2.  Of the covariates tested only age, 
presence of physical illness, and smoking were significantly associated with death from cancer.  
There was no significant association between cortisol and cancer mortality.  However, in age 
adjusted models, higher DHEAS concentrations were associated with a reduced risk of death from 
cancer, HR = 0.40, 95%CI = 0.22 – 0.71, p = .002, and a higher cortisol:DHEAS ratio was 
associated with an increased cancer mortality risk, HR = 1.94, 95%CI = 1.13 – 3.34, p = .02.  In the 
fully adjusted models, higher DHEAS concentrations were still related to lower mortality risk, HR = 
0.40, 95%CI = 0.23 – 0.70, p = .001, and a higher cortisol:DHEAS ratio still associated with an 
increased risk of death from cancer, HR = 2.04, 95%CI = 1.19 – 3.48, p = .01.     
 
[Insert Table 2 about here] 
 
Non medical and other causes of death 
The univariate hazard ratios predicting death from non medical causes are presented in Table 3.  
Those who died from non medical causes had smaller household incomes in mid life.  In age 
adjusted models, cortisol, DHEAS, and their ratio were not associated with non-medical causes of 
death.  The univariate predictions of mortality from other causes are also summarised in Table 3.  
Those who died from other causes were more likely to be smokers, consumed more alcohol, had 
higher blood pressure, were less likely to be white, had a lower household income in mid life, were 
less likely to be married and more likely to have a diagnosed chronic illness.  In the age and fully 
Post-print, not final published version. Cite this article as: Phillips, A.C., Carroll, D., Gale, C.R., 
Lord, J.M., Arlt, W., & Batty, G.D. (2010). Cortisol, dehydroepiandrosterone sulphate, their ratio 
and all-cause and cause-specific mortality in the Vietnam Experience Study. European Journal 
of Endocrinology, 162, 919-923. http://dx.doi.org/10.1530/EJE-09-1078 
 
 
adjusted models, cortisol was not associated with other causes of death, but DHEAS was again 
protective, HR = 0.33, 95%CI 0.21 − 0.51, p < .001, and HR = 0.45, 95%CI 0.30 − 0.67, p < .001, 
respectively.  A higher cortisol:DHEAS ratio was related to an increased risk of death by other 
causes in age adjusted, HR = 3.11, 95%CI 2.07 − 4.66, p < .001, and fully adjusted models, HR = 
2.11, 95%CI 1.46 − 3.06, p < .001.  In the fully adjusted models, the other predictors of death from 
other causes were smoking, high alcohol consumption, high resting SBP, not being married, not 
being white, low income in midlife, and pre-existing physical illness. 
 
[Insert Table 3 about here] 
 
Discussion 
In a population of male Vietnam era war veterans, age- and fully-adjusted analyses showed that 
DHEAS was associated with a reduced risk of all-cause, cancer, and other cause mortality.  A 
higher cortisol:DHEAS ratio was associated with an increased risk of death from all causes, cancer, 
and other causes.  DHEAS and the cortisol:DHEAS ratio were not associated with death from 
cardiovascular disease or non-medical causes.  For the most part, cortisol concentrations did not 
predict mortality.  Although there was a positive association between cortisol and all-cause 
mortality in the analysis that adjusted only for age, this was attenuated to non-significance in the 
fully adjusted model. 
 
These findings are concordant with those of previous studies where DHEAS has been shown to be 
protective against all-cause mortality in a variety of populations 17-20.  Although negative 
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associations between DHEAS concentrations and cardiovascular disease mortality have been 
reported 20, 31, which was not evident in the present sample, it is possible that this was a result of the 
older age (64 years+) of the participants in the previous studies, who would have naturally 
decreased DHEAS levels associated with ageing 32.  Only one study has demonstrated an 
association between DHEAS and cardiovascular mortality in men aged 30-80 years old 33.  In 
others, the association between DHEAS levels and cardiovascular disease mortality was lost after 
adjustment for a range of CVD risk factors34.   Of the few studies examining the cortisol:DHEAS 
ratio and total mortality, our findings confirm previous links 4.  The failure of cortisol alone to 
predict mortality contrasts with some previous findings 12-14, but is in agreement with others 9, 15.  
As we state above, DHEAS decreases with age 32, thus increasing the relative levels of cortisol, so it 
is possible that cortisol influences mortality in older as opposed to middle aged populations.   
 
The extension to the literature that the present study provides is the evidence of associations with 
cancer and other cause mortality for both DHEAS and the cortisol:DHEAS ratio.  These findings 
are not surprising given that the majority of other medical causes of death were largely infectious 
and immune (e.g. HIV) diseases, and that both cortisol and DHEA/DHEAS have been proposed to 
have a role in regulating immune function 5, 10, 23, 24; DHEA/DHEAS is also considered protective 
against the immunosuppressive actions of cortisol 7.  There is also evidence that treatment with 
DHEA can enhance immune function in humans with low DHEA/DHEAS levels 35, and increase 
immune function in animals 36, 37, although the benefits of DHEA supplementation on immunity in 
general remain controversial 6, 38, 39.  Taken together, the data suggest that DHEA might contribute 
to mortality via immune function effects.  Although we grouped malignancy sub-types that do not 
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have a unifying aetiology into a single category, in general cancer is similarly an immune-regulated 
disease (see e.g., 40), and links are evident between an altered HPA axis and inflammation in cancer 
patients 41.  It has also been suggested that low DHEA/S levels are associated with the initiation of 
cancer 42, suggesting a possible pathway by which lower DHEA/S concentrations and a higher 
cortisol:DHEA/S ratio could relate to cancer mortality.   
 
It is perhaps not surprising that externally caused mortality was not significantly related to cortisol, 
DHEAS, or the cortisol:DHEAS ratio in this sample, given that it is difficult to conceive of 
mechanisms by which altered levels of such hormones would increase the likelihood of death from 
suicide, homicide, or accidents.   
 
It is possible that the stress of army service could also contribute to neuroendocrine changes which 
in turn contribute to future morbidity and to the exacerbation of current disease, resulting in earlier 
mortality in this particular population.  Others have suggested that inadequate adrenal functioning 
may be related to both psychological reactions to exposure to the stress of war and the biologic 
vulnerability to disease 43.  Indeed, chronic stress has been associated with alterations in HPA axis 
function 44 and changes in leukocyte trafficking and function (Chrousos, 1995).  However, the 
mechanisms by which such stress-induced changes might relate to premature mortality are likely to 
be complex and diverse.   
 
The present study has a number of limitations.  First, in observational studies it is not possible to 
determine causality.  It is possible that lower DHEAS and a high cortisol:DHEAS ratio may be 
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markers for some or several unmeasured factors related to mortality, rather than a cause per se.  For 
example, a high cortisol:DHEAS ratio might result from extant disease.  Low DHEA secretion, for 
example, is frequently observed in patients with an adrenal cortisol-producing adenoma.  However, 
the present findings for DHEAS and the cortisol:DHEAS ratio survived adjustment for a pre-
existing diagnosis of cancer, diabetes and heart disease, and the circulating cortisol levels measured 
in this cohort are not unusually elevated, nor DHEAS unusually attenuated.  Nevertheless, 
experimental studies would be necessary to establish a causal relationship.  Second, the sample was 
exclusively male so these findings cannot be readily generalised to women.  However, given that 
premenopausal women have lower circulating DHEAS 45, it is possible that the relationship 
between cortisol:DHEAS ratio and mortality in women might be even stronger.  Third, this study 
only used a single morning measurement of serum cortisol and DHEAS.  Cortisol has a diurnal 
rhythm which would be best captured through multiple measurements.  However, the timing of the 
present samples was for the most part invariant across participants.  Further, DHEAS concentrations 
remain stable throughout the day and reflect the 24-hour secretion of DHEA 46, 47.   
 
In conclusion, in a sample of male Vietnam era war veterans, lower DHEAS and a higher 
cortisol:DHEAS ratio were associated with an increased risk of all-cause, cancer, and other cause 
mortality.  Further, experimental studies would be necessary to elucidate mechanisms further and 
establish causality.   It would be particularly instructive to examine the effects of DHEA 
supplementation in individuals with lower DHEA/S levels and/or high cortisol:DHEA/S ratios on 
mortality. 
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Table 1: Univariate hazard ratios (95% confidence intervals) predicting all-cause mortality. 
 
  
All-cause mortality (N = 236) 
  
HR (95% CI) 
 
p 
Age at medical examination (years) 1.04 (0.99 – 1.09) .13 
Units of alcohol per week 1.01 (1.01 – 1.02) < .001 
Systolic Blood Pressure (mmHg)  1.02 (1.01 – 1.03) .001 
Cortisol (µg/dL) logged 1.72 (1.13 – 2.64) .01 
DHEAS (µg/dL) logged 0.50 (0.38 – 0.65) <.001 
Cortisol : DHEAS logged 2.07 (1.63 – 2.64) <.001 
Place of service                        Other overseas 
                                                            US only 
                                               Ever in Vietnam 
0.71 (0.51 – 0.98) 
0.76 (0.53 – 1.08) 
referent 
.04 
.12 
- 
Ethnicity:                                                 Black 
                                                                 Other 
                                                                 White                    
2.28 (1.67 – 3.13) 
1.88(1.22 – 2.92) 
referent 
<.001 
.004 
- 
Household income in midlife             <$20,000 
                                                            -$40,000 
                                                           >$40,000 
4.18 (2.62 – 6.66) 
2.20 (1.38 – 3.51) 
referent 
<.001 
.001 
referent 
Smoking Status:                         Current smoker 
                                                          Ex smoker 
                                                        Non smoker 
2.01 (1.43 – 2.83) 
0.94 (0.62 – 1.44) 
referent 
< .001 
.78 
referent 
Marital Status:                             Never married 
                            Divorced/separated/widowed 
                                                               Married 
2.53 (1.75 – 3.66) 
2.32 (1.73 – 3.10) 
referent 
< .001 
< .001 
referent 
Physical Illness                                            Yes 
diabetes/hypertension/cancer or CHD          No 
2.38 (1.78 – 3.18) 
referent 
< .001 
referent 
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Table 2: Univariate hazard ratios (95% confidence intervals) predicting mortality from CVD and 
cancer 
 
  
Died: CVD (N = 63) 
 
 
Died: Cancer (N =47) 
  
HR (95% CI) 
 
p 
 
HR (95% CI) 
 
 
p 
Age at medical examination (years) 1.13 (1.02 – 1.24) .02 1.15 (1.03 – 1.29) .01 
Units of alcohol per week 1.01 (0.99 – 1.02) .29 1.01 (0.99 – 1.02) .26 
SBP (mmHg) 1.03 (1.02 – 1.05) <.001 1.02 (0.99 – 1.04) .10 
Cortisol (µg/dL) logged 2.21 (0.96 – 5.06) .06 0.86 (0.34 – 2.18) .74 
DHEAS (µg/dL) logged 0.77 (0.44 – 1.35) .36 0.37 (0.21 – 0.64) <.001 
Cortisol : DHEAS 1.62 (1.00 – 2.62) .05 2.15 (1.26 – 3.66) .005 
Place of service                          Other overseas 
                                                              US only 
                                               Ever in Vietnam 
0.46 (0.22 – 0.95) 
0.82 (0.43 – 1.56) 
referent 
.04 
.54 
referent 
1.08 (0.55 – 2.09) 
0.88 (0.40 – 1.95) 
referent 
.82 
.76 
referent 
Ethnicity                                                     Black 
Other 
White 
1.98 (1.05 – 3.76) 
2.11 (0.95 – 4.69) 
referent 
.04 
.07 
referent 
1.12 (0.47 – 2.64) 
0.68 (0.17 – 2.83) 
referent 
.80 
.60 
referent 
Household income in midlife               <$20,000 
                                                 -$40,000 
                                                   >$40,000 
3.74 (1.55 – 9.03) 
2.12 (0.88 – 5.12) 
referent 
.003 
.09 
referent 
1.37 (0.54 – 3.48) 
1.76 (0.77 – 4.02) 
referent 
.51 
.18 
referent 
Smoking Status:                        Current smoker 
                                                          Ex smoker 
                                                        Non smoker 
2.14 (1.07 – 4.30) 
1.35 (0.61 – 3.00) 
referent 
.03 
.47 
referent 
3.49 (1.35 – 8.99) 
1.97 (0.69 – 5.67) 
referent 
.009 
.21 
referent 
Marital Status:                            Never married 
                            Divorced/separated/widowed 
                                                               Married 
1.40 (0.59 – 3.30) 
1.95 (1.12 – 3.41) 
referent 
.44 
.02 
referent 
0.54 (0.13 – 2.23) 
1.36 (0.69 – 2.69) 
referent 
.42 
.37 
referent 
Physical Illness                                              Yes 
diabetes/hypertension/cancer or CHD           No 
3.60 (2.14 – 6.04) 
referent 
<.001 
referent 
2.05 (1.04 – 4.02) 
referent 
.04 
referent 
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Table 3: Univariate hazard ratios (95% confidence intervals) predicting mortality from external and 
other causes of death 
 
  
Died: External (N = 63) 
 
 
Died: Other (N =47) 
  
HR (95% CI) 
 
p 
 
HR (95% CI) 
 
 
p 
Age at medical examination (years) 0.93 (0.83 – 1.04) .20 0.98 (0.89 – 1.07) .64 
Units of alcohol per week 1.01 (0.99 – 1.02) .19 1.02 (1.01 – 1.02) <.001 
SBP (mmHg) 0.98 (0.96 – 1.01) .14 1.02 (1.00 – 1.04) .02 
Cortisol (µg/dL) logged 1.86 (0.74 – 4.66) .18 2.08 (0.98 – 4.45) .06 
DHEAS (µg/dL) logged 0.76 (0.40 – 1.41) .38 0.34 (0.22 – 0.53) <.001 
Cortisol : DHEAS 1.54 (0.90 – 2.63) .11 2.95 (1.98 – 4.40) <.001 
Place of service                          Other overseas 
                                                              US only 
                                               Ever in Vietnam 
0.57 (0.27 – 1.18) 
0.68 (0.31 – 1.46) 
referent 
.13 
.32 
referent 
0.84 (0.49 – 1.46) 
0.69 (0.36 – 1.32) 
referent 
.54 
.26 
referent 
Ethnicity                                                     Black 
Other 
White 
1.08 (0.46 – 2.55) 
1.65 (0.65 – 4.18) 
referent 
.86 
.29 
referent 
5.03 (3.08 – 8.21) 
3.07 (1.49 – 6.33) 
referent 
<.001 
.002 
referent 
Household income in midlife               <$20,000 
                                                 -$40,000 
                                                   >$40,000 
4.57 (1.60 – 13.20) 
2.63 (0.91 – 7.59) 
referent 
.005 
.07 
referent 
9.35 (3.37 – 25.94) 
2.63 (0.91 – 7.59) 
referent 
<.001 
.07 
referent 
Smoking Status:                        Current smoker 
                                                          Ex smoker 
                                                        Non smoker 
1.87 (0.89 – 3.93) 
1.20 (0.50 – 2.84) 
referent 
.10 
.68 
referent 
1.60 (0.93 – 2.73) 
0.30 (0.12 – 0.75) 
referent 
.09 
.01 
referent 
Marital Status:                            Never married 
                            Divorced/separated/widowed 
                                                               Married 
1.97 (0.87 – 4.47) 
1.57 (0.81 – 3.05) 
referent 
.10 
.18 
referent 
7.92 (4.41 – 14.22) 
5.26 (3.08 – 9.00) 
referent 
<.001 
<.001 
referent 
Physical Illness                                              Yes 
diabetes/hypertension/cancer or CHD           No 
1.61 (0.81 – 3.22) 
referent 
.17 
referent 
2.26 (1.35 – 3.82) 
referent 
.002 
referent 
 
